Founding Group

Professor Helen Storr is a Professor and Honorary Consultant in Paediatric Endocrinology at Queen Mary University London (QMUL) and Barts Health Trust, London. She leads an active programme of clinical and basic science research with key interests in the recognition, diagnosis, and management growth disorders and their molecular genetic basis. She is a member of the Editorial Board for the Journal of Clinical Endocrinology and Metabolism, medical advisor for the Child Growth Foundation (CGF) and Chairs the British Society For Paediatric Endocrinology and Diabetes (BSPED) Growth Disorders Special Interest Group.

Peter Clayton is Emeritus Professor of Child Health and Paediatric Endocrinology at the University of Manchester. For 30 years he has been a clinical consultant at the Royal Manchester Children’s Hospital and at the Christie (Cancer) Hospital. His primary research interest is centred on understanding mechanisms leading to disordered growth, using clinical, genomic, in-vitro and in-vivo approaches. He has led a research team of clinicians and scientists, whose work has spanned basic science through to clinical trials, with a focus on translation to patient care. His clinical interests include late endocrine effects of childhood cancer treatment and the transition of young people with chronic endocrine conditions through to adult care. He now advises on clinical trials for an oral growth hormone secretagogue in growth disorders

Professor Gary Butler, specialises in growth, puberty and male reproductive disorders and transgender endocrinology. He is honorary Professor at the Great Ormond Street Institute of Child Health and former Consultant at University College London Hospital. He jointly redesigned the current UK growth charts. He received the 2020 ESPE Outstanding Clinician Award for his clinical and research contributions.

Professor Justin Davies is Professor of Paediatric Endocrinology at the University of Southampton, UK. His research interests include growth and imprinting disorders (including Silver-Russell and Temple syndrome), secondary osteoporosis and care for children with differences of sex development. He Co-Chairs the British Society of Paediatric Endocrinology and Diabetes Growth Disorders Special Interest Group, and is developing a standardised national approach to growth assessment and management of growth disorders.